ARWR
Price
$19.56
Change
+$0.54 (+2.84%)
Updated
Jan 17 closing price
Capitalization
2.43B
17 days until earnings call
TSHA
Price
$1.53
Change
-$0.05 (-3.16%)
Updated
Jan 17 closing price
Capitalization
313.56M
66 days until earnings call
Ad is loading...

ARWR vs TSHA

Header iconARWR vs TSHA Comparison
Open Charts ARWR vs TSHABanner chart's image
Arrowhead Pharmaceuticals
Price$19.56
Change+$0.54 (+2.84%)
Volume$931.55K
Capitalization2.43B
Taysha Gene Therapies
Price$1.53
Change-$0.05 (-3.16%)
Volume$1.92M
Capitalization313.56M
ARWR vs TSHA Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. TSHA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Hold and TSHA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ARWR: $19.56 vs. TSHA: $1.53)
Brand notoriety: ARWR: Notable vs. TSHA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 53% vs. TSHA: 46%
Market capitalization -- ARWR: $2.43B vs. TSHA: $313.56M
ARWR [@Biotechnology] is valued at $2.43B. TSHA’s [@Biotechnology] market capitalization is $313.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $352.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, ARWR is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 3 bullish TA indicator(s).

  • ARWR’s TA Score: 3 bullish, 4 bearish.
  • TSHA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than TSHA.

Price Growth

ARWR (@Biotechnology) experienced а +5.79% price change this week, while TSHA (@Biotechnology) price change was -13.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

ARWR is expected to report earnings on May 08, 2025.

TSHA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.43B) has a higher market cap than TSHA($314M). ARWR YTD gains are higher at: 4.043 vs. TSHA (-11.561). TSHA has higher annual earnings (EBITDA): -20.67M vs. ARWR (-561.51M). ARWR has more cash in the bank: 681M vs. TSHA (158M). TSHA has less debt than ARWR: TSHA (62.5M) vs ARWR (511M). TSHA has higher revenues than ARWR: TSHA (9.92M) vs ARWR (3.55M).
ARWRTSHAARWR / TSHA
Capitalization2.43B314M775%
EBITDA-561.51M-20.67M2,716%
Gain YTD4.043-11.561-35%
P/E RatioN/A2.43-
Revenue3.55M9.92M36%
Total Cash681M158M431%
Total Debt511M62.5M818%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRTSHA
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
69%
Bullish Trend 6 days ago
86%
Momentum
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 6 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 6 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 21 days ago
83%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
75%
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Ad is loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with NTLA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+2.84%
NTLA - ARWR
49%
Loosely correlated
+0.85%
CRNX - ARWR
48%
Loosely correlated
+2.38%
BEAM - ARWR
46%
Loosely correlated
+0.17%
DNLI - ARWR
44%
Loosely correlated
+1.20%
FATE - ARWR
43%
Loosely correlated
+1.60%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with ARWR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-3.16%
ARWR - TSHA
35%
Loosely correlated
+2.84%
TRDA - TSHA
35%
Loosely correlated
+1.20%
AURA - TSHA
34%
Loosely correlated
+1.30%
PRME - TSHA
34%
Loosely correlated
+0.70%
DNA - TSHA
33%
Loosely correlated
+6.18%
More